US2023272336A1PendingUtilityA1
Cell culture method using amino acid-enriched medium
Assignee: CHUGAI PHARMACEUTICAL CO LTDPriority: Apr 26, 2007Filed: Apr 28, 2023Published: Aug 31, 2023
Est. expiryApr 26, 2027(~0.7 yrs left)· nominal 20-yr term from priority
Inventors:Satoshi KatayamaShouhei KishishitaKunihiko KodairaMakoto SadamitsuYoshinori TakagiHiroki Matsuda
C12N 5/0018C07K 16/2866C07K 16/303C12P 21/02C07K 2317/24C12N 2500/32C12N 2500/33C12N 2510/02C12N 5/00A61P 37/04C12N 15/11C12N 5/10C12P 21/00
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of culturing cells capable of producing desired proteins to obtain the proteins by use of a medium from which biological components are excluded as much as possible are provided. Specifically, a culture method characterized by culturing while maintaining a specific amino acid in a culture solution at a high concentration, and a cell culture fed-batch medium for use in the method are provided.
Claims
exact text as granted — not AI-modified1 . A method of culturing a cell comprising culturing a cell capable of producing a desired protein in a culture solution in which a concentration of serine in the culture solution is maintained at 1 mM or higher at least during a certain period after onset of a cell growth phase, and obtaining the desired protein.
2 . The method of claim 1 , wherein a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or at 0.4 mM or higher at least during the certain period after onset of the cell growth phase.
3 . A method of culturing a cell, comprising culturing a cell capable of producing a desired protein a culture solution in which a concentration of serine in the culture solution is maintained at 1 mM or higher at least during a part of or an entire period sufficient to enable the cell that is to be cultured to grow sufficiently, or during a part of or an entire period sufficient to enable adequate production of the desired protein that is to be produced.
4 . The method of claim 3 , wherein a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or at 0.4 mM or higher at least during a part of or the entire period sufficient to enable the cell that is to be cultured to grow sufficiently, or during a part of or the entire period sufficient to enable adequate production of the desired protein that is to be produced.
5 . A method of culturing a cell, comprising culturing a cell capable of producing a desired protein in a culture solution in which a concentration of serine in the culture solution is maintained at 1 mM or higher at least during a part of or an entire period of an exponential cell growth phase, and obtaining the desired protein.
6 . The method of claim 5 , wherein a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or higher or at 0.4 mM or higher at least during a part of or an entire period of the exponential cell growth phase.
7 . The method of claim 4 wherein the concentration of serine in the culture solution is maintained at 2 mM or higher at least during a part of or an entire period of the exponential cell growth phase.
8 . A method of culturing a cell, comprising culturing a cell capable of producing a desired protein in a culture solution in which a concentration of serine in the culture solution is maintained at 1 mM or higher at least during a part of or an entire period from a third day to a tenth day of the culture, and obtaining the desired protein.
9 . The method of claim 7 , wherein a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or higher or at 0.4 mM or higher at least during a part of or an entire period from the third day to the tenth day of the culture.
10 . The method of claim 8 , wherein the concentration of serine in the culture solution is maintained at 2 mM or higher at least during a part of or an entire period from the third day to the tenth day of the culture.
11 . The method of claim 1 , wherein the cell is cultured by batch culture, repeated batch culture, fed-batch culture, repeated fed-batch culture, continuous culture, or perfusion culture.
12 . The method of claim 1 , wherein the cell is cultured by fed-batch culture.
13 . The method of claim 12 , wherein the serine and tyrosine and/or cysteine are fed into the culture solution in multiple batches sequentially or continuously.
14 . The method of claim 1 , wherein the cell is transformed with a gene encoding the desired protein.
15 . The method of claim 14 , wherein the desired protein is an antibody.
16 . The method of claim 1 , wherein the cell is a mammal cell.
17 . The method of claim 16 , wherein the mammal cell is a CHO cell.
18 . A fed-batch medium for culturing a cell, comprising serine at a concentration of 10 mM to 1000 mM.
19 . A fed-batch medium for culturing a cell, comprising serine at a concentration of 20 mM to 500 mM.
20 . The fed-batch medium of claim 18 , further comprising cysteine and/or tyrosine.
21 . The fed-batch medium of claim 18 , further comprising cysteine and tyrosine.Join the waitlist — get patent alerts
Track US2023272336A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.